Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 BF2.649 in Japanese Patients with Narcolepsy
jRCT2031220432Phase 3Completed
- Sponsor
- Aculys Pharma, Inc.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy comparing BF2.649 with Placebo (2 arms). Started Nov 2022; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on jRCT2031220432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220432.